Figure 8. In vivo administration of CM-1315 improves vaccine efficacy.

BALB/c mice were immunized with AH1 peptide emulsified in IFA and treated with saline or with P60 or CM-1315 during 10 days (10 nanomol/mice/day). Ten days later, mice were challenged s.c. with 10⁶ CT26 tumor cells. Mean tumor volume for each group (A) and survival curves (B) are plotted.